A total of EUR 32.5 million has been raised by RSP Systems based on progress in developing and commercializing its non-invasive GlucoBeam™. The company is now in a Series C round of funding, which will support final technology development and preparation for their upcoming pivotal study anticipated in 2022. The current round is expected to […]
Our goal is to make glucose monitoring so unintrusive that it sets a new standard of care.
We strive to improve access to health information through glucose measurement, for all people who can benefit from understanding their glucose level.